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Abstract The field of tissue engineering entered a new era with the development of human
pluripotent stem cells (hPSCs), which are capable of unlimited expansion whilst retaining the
potential to differentiate into all mature cell populations. However, these cells harbor significant
risks, including tumor formation upon transplantation. One way to mitigate this risk is to develop
expandable progenitor cell populations with restricted differentiation potential. Here, we used a
cellular microarray technology to identify a defined and optimized culture condition that supports
the derivation and propagation of a cell population with mesodermal properties. This cell population,
referred to as intermediate mesodermal progenitor (IMP) cells, is capable of unlimited expansion,
lacks tumor formation potential, and, upon appropriate stimulation, readily acquires properties of a
sub-population of kidney cells. Interestingly, IMP cells fail to differentiate into other mesodermally-
derived tissues, including blood and heart, suggesting that these cells are restricted to an
intermediate mesodermal fate.
DOI: 10.7554/eLife.08413.001
Introduction
Human pluripotent stem cells (hPSCs; including human embryonic stem [hES] cells and human induced
pluripotent stem [hiPS] cells) have the potential to generate the various cell types of the adult body.
With their capacity to expand indefinitely, hPSCs provide a potentially unlimited source of mature cell
types that can be used for disease modeling, drug discovery, and regenerative medicine purposes.
Current methods for generating these therapeutically relevant cell types follow a linear approach in
which hPSCs are differentiated in small, discrete steps that mimic the sequence of events occurring
during development. The initial step typically involves specification of hPSCs into one of the three
embryonic germ layers—ectoderm (EC), endoderm (EN), or mesoderm.
In the case of mesoderm, several protocols have been developed to derive mature tissues
stemming from this lineage, including muscle, blood, and urogenital cells (Kee and Reijo Pera, 2008;
Ng et al., 2008; Lian et al., 2012; Taguchi et al., 2014). While these studies have demonstrated the
potential of hPSC-derived mesodermal tissues for cell replacement therapies, these protocols result in
the generation of heterogeneous cell populations, some with tumor forming potential, which limits
their clinical utility. Additionally, because of the inefficiency of these established protocols, large
numbers of input cells are necessary to generate cell types in the quantities necessary for clinical
applications.
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Expansion of intermediate progenitor populations of differentiating hPSCs followed by subsequent
differentiation is an alternative approach for generating highly enriched and well-defined cell
populations required for cell-based therapies and disease modeling. For example, homogenous,
expandable ectodermally- and endodermally-restricted progenitor populations have been generated
from hPSCs (Reubinoff et al., 2001; Shin et al., 2006; Chambers et al., 2009; Cheng et al., 2012).
However, similar methods to generate cell types restricted to the mesodermal lineage have yet to be
developed.
The cell microenvironment plays a critical role for regulating self-renewal and differentiation of
many progenitor cell populations that exist within the developing and fully mature adult organism
(Moore and Lemischka, 2006; Jones and Wagers, 2008). In this study, we used a multifactorial high-
throughput screening technology (Flaim et al., 2005; Brafman et al., 2012) to engineer in vitro
microenvironments that allow for the homogenous expansion of a hPSC-derived mesodermally
restricted progenitor population, which we refer to as mesodermal progenitors (MPs). Gene
expression analysis and differentiation assays indicated that these cell lack tumor forming potential
and exhibit properties associated with intermediate mesoderm, an observation that led us to re-name
MP cells as intermediate mesodermal progenitor (IMP) cells. Upon modulation of their culture
conditions, IMPs readily generate cell types of the renal lineage. Interestingly, IMP cells fail to
differentiate into other mesodermal lineages, such as blood and cardiac muscle. Therefore, IMP cells
provide a useful tool to not only study the mechanisms that regulate human mesoderm development
but also a homogenous, non-tumorigenic cell source for regenerative medicine purposes.
Results
ACME screen to identify culture conditions of MP cells
Using a high-throughput screening platform previously developed in our laboratory referred to as
arrayed cellular microenvironments (ACMEs, [Brafman et al., 2012]) we sought to identify culture
conditions to derive, maintain and expand a cell population with mesodermal properties from hPSCs
(including human embryonic and human induced pluripotent stem [hES and iPS] cells). To readily
observe and detect acquisition of a mesodermal phenotype, we utilized the hES cell line H9/WA09
eLife digest The development of ‘human pluripotent stem cells’ has the potential to
revolutionize the future of medicine. This is because these cells can both replicate themselves
indefinitely (i.e., they can self-renew) and develop into any of the cell types found in the human body
(a process that is referred to as differentiation). These abilities mean that the cells could in theory be
used to replace any tissues or organs that have been damaged by disease or injury. Unfortunately,
transplanting stem cells that are capable of developing into any type of cell comes with the
significant risk that these cells will form into a tumor.
Once a cell has started to differentiate it can typically only go on to generate a restricted number
of cell types. However, these differentiating cells also generally lose their ability to self-renew. Kumar
et al. set out to challenge this fundamental property of differentiating cells. A high throughput-
screening approach was used to test thousands of combinations of bioactive molecules (i.e.,
molecules that are known to affect living cells in different ways) to identify some that could promote
the self-renewal of cells with a restricted potential to differentiate.
Kumar et al. found specific conditions that could cause a population of cells, which they referred
to as ‘intermediate mesodermal progenitor cells’ (or IMP cells for short), to self renew. These cells
resemble those found in the middle layer of a very early human embryo, which typically go on to
develop into only a subset of tissue types in the body—for example, muscle, kidneys and blood
vessels, but not brain or lungs. Yet, when Kumar et al. stimulated the self-renewing IMP cells, these
cells only differentiated into the cell types that make up the kidney and not any other types of cell.
This tight restriction on the differentiation potential of these cells is highly important, because it
means that these cells could greatly advance methods to generate kidney cells or even whole kidneys
in the laboratory that are suitable for transplantation.
DOI: 10.7554/eLife.08413.002
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harboring the gene encoding green fluorescent protein (GFP) under the control of the Brachyury (T)
promoter (referred to as H9-T-GFP; [Kita-Matsuo et al., 2009]). Brachyury, which is expressed early in
embryonic development in the primitive streak, is transiently expressed as hPSCs exit the pluripotent
state and differentiate into mesodermal (ME) lineages (Rivera-Perez and Magnuson, 2005).
To induce mesodermal differentiation, we treated H9-T-GFP cells with the GSK3 inhibitor
CHIR98014 (CHR) for 2 days, at which point cells uniformly expressed GFP (Figure 1A) and were
seeded onto ACME slides printed with combinations of bioactive molecules. We performed two
sequential screens to identify conditions that maintain GFP expression over a 3-day period: a first
screen to identify an optimal substrate composed of extracellular matrix proteins (ECMPs), and a
second screen to identify growth factors (GFs) and small molecules (SMs) (Figure 1A). The second
screen was performed using the optimal substrate composition identified in the first screen. GFP
expression for each condition was evaluated and quantified using a high content imaging system and
software.
In the first screen, all possible 128 combinations of 7 purified ECMPs (Collagen 1, 3, 4, 5 [C1 C3 C4
C5], Fibronectin [FN], Laminin [LN], Vitronectin [VN]), were tested for their ability to support
attachment and maintain GFP expression. Hit conditions were defined as those ECMP combinations
that supported maximal cell numbers, as well as GFP expression. The distribution of total cell number
and GFP signal intensity across conditions was summarized in a normalized, clustered heat map
(Figure 1B). Interestingly, several defined ECMP combinations increased total cell number relative to
Matrigel, a commercially available extracellular matrix that is commonly used for growth of hPSCs and
their derivatives. Further, several ECMP combinations maintained expression of GFP to a greater
extent than Matrigel. Cells growing on one of these representative ‘hit’ conditions (C1 C3 C4 FN VN)
is shown in Figure 1C.
For the second GF and SM screen, we used one of the optimal matrix compositions (C1 C3 C4 FN
VN) as a substrate to deposit combinations of up to three GF and SM, which are known to exert
potent effects during early developmental processes. Certain factor combinations increased, while
others decreased, cell number and GFP expression (Figure 1D). Conditions with positive effects in this
assay contained a Wnt agonist (either Wnt3a [WNT] or CHR) and a member of the FGF superfamily
(Figure 1D,E). Consistent with this observation, a global main effects principal component analysis of
all GF and SM revealed that CHR, WNT, Rspondin and FGF exerted the most potent effects on GFP
expression (Figure 1—figure supplement 1). To a lesser extent, the FGF family members VEGF (VGF)
and KGF, also positively influenced GFP expression, whereas Wnt antagonists (DKK1 and IWP2)
negatively influenced GFP expression.
We confirmed the ECMP hit conditions by scaling up the 10 top-performing matrix compositions
shown in the heatmap of Figure 1B into traditional cell culture formats. Compared to Matrigel and a
sub-optimal matrix (C1 C4 C5 LN), 8 of the 10 ECMP hit conditions significantly increased the
percentage of GFP positive cells (Figure 2A). Importantly, in this scaled-up format, the optimal matrix
identified in the primary screen (C1 C3 C4 FN VN) consistently led to higher cell numbers and GFP
expression compared to the other top ECMP combinations, thus demonstrating the robustness of the
ACME screening platform.
We also plated cells in traditional cell culture format on the optimized matrix in the presence of
individual soluble factors as well as the top 27 combinatorial hits from the GF-SM screen (Figure 2B).
This analysis confirmed that the combination of CHR and FGF yielded the highest level of GFP
expression and cell number. Since bioactive molecules like CHR (or Wnt) and FGF often exhibit
distinct effects at varying concentrations, we performed a dose response analysis to identify optimal
CHR and FGF concentrations. The optimal CHR dose was 1.0 μM while the dose of FGF was less
dynamic, with its effects saturating at 20 ng/ml FGF (Figure 2C).
Expansion of a mesodermal cell population in defined conditions
The previous analysis was performed 3 days after plating cells in the optimized culture condition. We
also examined to what extent this optimized culture condition could support long term growth and
expansion of cells with mesodermal properties (Figure 3A), which we preliminarily referred to as MP
cells. In addition, we extended this analysis to include two additional cell lines, BJ-RiPS and HUES9
cells. When seeded at a density of 104 cells/cm2, cells formed and grew in tight clusters (Figure 3B).
Cells with these morphological properties were expanded by serial passaging with approximate
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Figure 1. Arrayed cellular microenvironment (ACME) screen identified conditions that maintain expression of the
mesodermal reporter T-GFP. (A) Schematic of the ACME experimental design. Human ES cells carrying a green
fluorescent protein (GFP) reporter under control of the BRY/T promoter were treated with CHIR98014 (CHR). GFP
positive (T-GFP) cells were seeded onto ACME slides printed with combinations of extracellular matrix proteins
(ECMPs), growth factors (GF) and small molecules (SMs). A primary screen contained all possible combinations of
ECMP Collagen I (C1), Collagen III (C3), Collagen IV (C4), Collagen V (C5), Fibronectin (FN), Laminin (LN), and
Vitronectin (VN). A second GF and SM screen contained all possible single, pairwise, and three-way combinations of
Wnt3a (WNT), CHIR98014 (CHR), Rspondin (RSP), Dkk-1 (DKK), IWP-2 (IWP), FGF-2 (FGF), FGF-7 (KGF), VEGF (VGF),
EGF (EGF), SHH (SHH), Activin (ACT), Cyclopamine (CYC), Dorsomorphin (DSM), BMP4 (BMP), SB4-31542 (SB4), and
Noggin (NOG). The second screen was performed on the optimal ECMP combination identified in the primary
screen. 72 hr after seeding, GFP expression and DAPI staining were captured and analyzed using a high content
imaging microscope. (B) Results of the primary ECMP screen. A heat map of average T-GFP intensity was generated
showing the distribution across the data set. Representative clusters are magnified. The position of the Matrigel
condition in the cluster is also indicated for reference. Rows represent different ECMP combinations. Columns 1–3
represent biological replicates for cell number (Cell #) or T-GFP (GFP). Columns marked X represent the average of
the three biological replicates. (C) Representative images of ECMP conditions in the array format. Matrigel is shown
Figure 1. continued on next page
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doubling rates of 60.2 ± 4.2 hr (H9 = 55.4 hr, Figure 3C; Hues9 = 61.8 hr, RiPS = 63.4 hr,
Figure 3—figure supplement 1) and expressed the proliferation marker Ki-67 (Figure 3—figure
supplement 2). Cell counts taken at each passage revealed that 1 × 104 cells could theoretically be
expanded to approximately 1 × 1012 cells over 10 passages (Figure 3C and Figure 3—figure
supplement 1). These cells maintained 46 chromosomes (Figure 3—figure supplement 3), indicating
that cultured cells did not acquire abnormal chromosome numbers commonly associated with late
passage hPSCs. Reverse transcription quantitative PCR (qPCR) showed that expression of genes
associated with pluripotency (OCT4, NANOG, SOX2) was rapidly lost during expansion (Figure 3D;
Figure 3—figure supplement 4). This loss of pluripotency-associated properties was further
confirmed by immunofluorescence (IF) staining (OCT4 and NANOG, Figure 3—figure supplement 5)
and flow cytometry (TRA-1-81 and SSEA4, Figure 3—figure supplement 6). In contrast, genes
associated with the mesoderm (ME) lineage (MESP1,MIXL1, LHX1) were upregulated and maintained
over 10 passages (Figure 3E; Figure 3—figure supplement 7). IF staining confirmed the presence of
MIXL1 protein in these expanded cell cultures (Figure 3F). Using flow cytometry, we furthermore
showed that the expanded cells shared a cell surface signature of CD56+ CD326− (Figure 3G;
Figure 3—figure supplement 8), previously defined for a multipotent mesoderm-committed cell
population (Evseenko et al., 2010). In addition, expression of the EN marker FOXA2 and the EC
marker SOX1 was significantly reduced in these cells (Figure 3H,I; Figure 3—figure supplements
9, 10).
The apparent indefinite expansion of MP cells (greater than 20 passages at the time of this
submission) raised the possibility that these cells, like undifferentiated hPSCs, harbored tumorigenic
potential. Importantly, unlike hPSCs, MP cells did not produce tumors when injected into immune
compromised mice (Figure 3J). Among the 12 MP cell injections (2 injections per mouse ranging
from 0.5 million to 1 million cells), only one site maintained a small lump (∼1 mm in diameter), which
did not grow in size over 12 weeks. In contrast, all 6 hPSC injections (0.5 million cells per injection)
produced readily visible teratomas (greater than 10 mm in diameter). Taken together, we have
generated a non-tumorigenic progenitor population capable of nearly indefinite expansion potential
with a mesodermal phenotype.
Optimized culture conditions are necessary to generate and maintain MP
cells
From the ACME screens, we identified a defined matrix (C1 C3 C4 FN VN) and combination of soluble
factors (CHR + FGF) that allow for the derivation and expansion of MP cells. We wanted to explore to
what extent these defined conditions were critical for the derivation and expansion of MP cells. To this
end, we first compared the effectiveness of our defined matrix relative to Matrigel and of CHR + FGF
relative to no factors in deriving MP cells (Figure 4A), as assayed by qPCR of mesodermal markers.
Importantly, cells cultured in the absence of CHR and/or FGF failed to passage beyond one passage,
indicating that these soluble factors are essential to the expansion of MP cells. Furthermore, although
Matrigel with CHR and FGF yielded cells expressing the mesodermal markers MESP1, MIXL1, and
Figure 1. Continued
in comparison to the hit condition C1 C3 C4 FN VN. Scalebar = 50 μm. (D) Results of the second GF and SM screen.
A heat map of average T-GFP intensity was generated showing the distribution across the data set. Representative
clusters are magnified. The position of the condition lacking GFs and SMs (No Factor) is also indicated for reference.
Rows represent different GF and SM combinations. Columns 1–3 represent biological replicates for cell number (Cell #)
or T-GFP (GFP). Columns marked X represent the average of the three biological replicates. (E) Representative images of
GF and SM conditions in the array format. No GF or SM is shown in comparison to the hit condition CHR + FGF. Scalebar
= 50 μm. Figure 1—figure supplement 1 provides a global main effects principal component analysis for all GF and SM
used in this second screen.
DOI: 10.7554/eLife.08413.003
The following figure supplement is available for figure 1:
Figure supplement 1. Global main effects principal component analysis of GF and SM ACME screen demonstrates
that WNT and FGF agonists exert positive effects on T-GFP expression.
DOI: 10.7554/eLife.08413.004
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LHX1, our optimized matrix significantly increased their expression (Figure 4B). By passage 3, cells
cultured in our optimized conditions expressed 1.5- to 2-fold greater levels of MESP1, MIXL1, and
LHX1 compared to cells cultured on Matrigel (Figure 4B).
Figure 2. Validation of high-throughput ACME screens. Scale up analysis of hits from the ACME screens. Human ES
cells carrying a GFP reporter under control of the BRY/T promoter were treated with CHIR98014 (CHR) for 24 hr. After
48 hr, GFP positive (T-GFP) cells were cultured in multi-well plates for 72 hr to validate conditions from the ACME
screens. (A) GFP+ cells were cultured in multi-well plates coated with 10 hit matrices from the primary ECMP screen as
well as Matrigel and a sub-optimal matrix (C1 C4 C5 LN). The optimal matrix (C1 C3 C4 FN VN) was defined as the
condition that maintained the highest T-GFP expression and fostered the highest cell number. Statistical comparisons
are made to the Matrigel condition. *p < 0.05, **p < 0.005. When p-values are not indicated with * or **, the statistical
difference is not significant from the control. (B) GFP+ cells were cultured in multi-well plates coated with the optimal
matrix (C1 C3 C4 FN VN) and various GF/SM combinations. Statistical comparisons are made to the conditions
containing no GF/SM (No Factor). *p < 0.05, **p < 0.005. When p-values are not indicated with * or **, the statistical
difference is not significant from the control. (C) GFP+ cells were cultured in multi-well plates coated with the optimal
matrix (C1 C3 C4 FN VN) and various concentrations of CHR and FGF2 (FGF).
DOI: 10.7554/eLife.08413.005
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Figure 3. Characterization of mesodermal progenitor population. (A) Schematic showing derivation of mesoderm
progenitor (MP) cells. Human ES cells were differentiated into mesoderm (ME) with CHIR98014 (CHR) and then
replated onto the defined substrate C1 C3 C4 FN VN and cultured with CHR and FGF2 (FGF) for up to 20 passages
(p0 to p20). (B) Representative images of MP cells derived from the hES cell line H9/WA09 at passage 1 and 10 in C1
C3 C4 FN VN with CHR and FGF. Scale bar = 50 μm. (C) Growth rate of MP cells derived from H9 T-GFP. Cell counts
were taken at each passage. (D) Quantitative PCR (qPCR) analysis for expression of pluripotency markers OCT4,
NANOG, and SOX2. Expression of these markers in MP cells at passages 1, 5 and 10 is lower than in undifferentiated
cells (ES). Cells differentiated into ME, endoderm (EN) and ectoderm (EC) served as controls. All statistical
comparisons are made to the ES sample. *p < 0.05, **p < 0.005. (E) qPCR analysis for expression of mesodermal
markers MESP1, MIXL1, and LHX1. Expression of these markers in MP cells at passages 1, 5 and 10 is comparable
to that observed in ME and higher than in ES, EN and EC. All statistical comparisons are made to the ME sample.
*p < 0.05, **p < 0.005. (F) MIXL1 immunofluorescence (IF) in MP cells. MP cells at passage 15 were fixed and stained
with MIXL1-specific antibody. Number indicates percentage of MIXL1 expressing cells in the MP cell population.
Figure 3. continued on next page
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Next, we compared the effectiveness of our defined matrix relative to Matrigel and of CHR + FGF
relative to no factors in maintaining MP cells (Figure 4C). For this analysis, MP cultures were grown in
the optimized conditions (C1 C3 C4 FN VN and CHR + FGF) through passage 6, at which point
cultures were either passaged onto Matrigel or the defined matrix in the presence or absence of the
soluble factors CHR and FGF. Again, the optimized culture condition produced a statistically
significant difference in maintaining mesoderm marker expression compared to other conditions
(Figure 4D). Importantly, MP cultures without CHR and FGF failed to expand beyond the first
passage. Taken together, these results indicate that the defined substrate C1 C3 C4 FN VN as well as
CHR and FGF are required for optimal MP cell generation and maintenance.
Global gene expression demonstrates an intermediate mesodermal (IM)
identity of MP cells
To further characterize the MP cell population derived and expanded under our defined culture
conditions, we performed transcriptome analysis by RNA sequencing (RNA-seq). For comparison, we
analyzed the transcriptomes of undifferentiated hES cells, as well as of transient EC, EN, ME populations
differentiated from hES cells. Cluster analysis of the RNA-seq data revealed that MP cells are more
similar to ME cells than they are to EC, EN, and hES cells (Figure 5A and Supplementary file 1A,B).
Comparison of expressed genes in MP and ME cell populations confirmed a high degree of similarity,
Figure 3. Continued
Standard deviation represents the variation between the fields of view used for counting (n = 20). Scale bar = 50 μm.
(G) Flow cytometry analysis for CD56 (NCAM) and CD326 (ECAM). Pluripotent cells (ES, CD326+ CD56−) are
differentiated to ME cells (CD326− CD56+). MP cells at p10 exhibit a similar cell surface expression of these two
markers as ME. (H) qPCR analysis for expression of the EN marker FOXA2. Expression of FOXA2 is only detected in
cells differentiated towards EN. All statistical comparisons are made to the ES sample. (I) qPCR analysis for
expression of the EC marker SOX1. Expression of SOX1 is only detected in cells differentiated towards EC. All
statistical comparisons are made to the ES sample. (J) MP cells are non-tumorogenic. Nude mice were injected with
H9-derived MP cells or H9 ES cells. Injected ES cells generated tumors while injected MP cells did not form any
growth in 11/12 injections. Figure 3—figure supplement 1 through 10 provide additional analysis, including for two
other hPSC lines (BJ RiPS and HUES9).
DOI: 10.7554/eLife.08413.006
The following figure supplements are available for figure 3:
Figure supplement 1. Growth rate of MP cells derived from Hues 9 or BJ RiPS.
DOI: 10.7554/eLife.08413.007
Figure supplement 2. Flow cytometry analysis of Ki-67 in human ES, ME, and MP.
DOI: 10.7554/eLife.08413.008
Figure supplement 3. Karyotype of MP cells derived from the hES cell line H9/WA09.
DOI: 10.7554/eLife.08413.009
Figure supplement 4. QPCR analysis for expression of pluripotency markers OCT4, NANOG, and SOX2.
DOI: 10.7554/eLife.08413.010
Figure supplement 5. IF of Hues 9 ES and MP cells demonstrate that MP cells do not express OCT4 and NANOG
proteins.
DOI: 10.7554/eLife.08413.011
Figure supplement 6. Flow cytometry analysis of Hues 9 ES and MP (p10) cells for Tra-1-81 and SSEA4.
DOI: 10.7554/eLife.08413.012
Figure supplement 7. QPCR analysis of MP cells derived from Hues 9 and BJ RiPS for expression of mesodermal
markers MESP1, MIXL1, and LHX1.
DOI: 10.7554/eLife.08413.013
Figure supplement 8. Flow cytometry analysis for CD56 (NCAM1) and CD326 (EPCAM) in undifferentiated RiPS cells
as well as ME and MP (p10) cells derived from RiPS cells.
DOI: 10.7554/eLife.08413.014
Figure supplement 9. QPCR analysis of MP cells derived from Hues 9 and BJ RiPS.
DOI: 10.7554/eLife.08413.015
Figure supplement 10. QPCR analysis of MP cells derived from Hues 9 and BJ RiPS.
DOI: 10.7554/eLife.08413.016
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Figure 4. Optimized culture conditions are required to generate and maintain MP cells. (A) Human ES cells were
treated with CHIR98014 (CHR) for 24 hr. After 48 hr, cells were cultured on either Matrigel or the optimal matrix
(C1 C3 C4 FN VN) in the absence (no factor) or in the presence of the optimal GF/SM combination (CHR + FGF).
Only cells cultured with CHR + FGF could be serially passaged. (B) QPCR analysis for mesodermal markers MESP1,
MIXL1, and LHX1. Conditions containing no factor did not grow beyond passage 1, while the CHIR + FGF samples
represent expression at passage 3. NF = no factor; C + F = CHR + FGF. Statistical comparisons are made to C1 C3
C4 FN VN with CHR + FGF condition. *p < 0.05, **p < 0.005. (C) MP cells were expanded to p6 on the optimal ECMP
(C1 C3 C4 FN VN) and GF/SM combination (CHR + FGF). MP cells were then either transitioned to Matrigel or
maintained on C1 C3 C4 FN VN in the absence or presence of CHR + FGF. (D) QPCR analysis for mesodermal
markers MESP1, MIXL1, and LHX1. Conditions containing no factor did not grow past p7, while the CHR + FGF
sample represents expression at p9. All statistical comparisons are made to the C1 C3 C4 FN VN with CHR + FGF
condition. *p < 0.05, **p < 0.005.
DOI: 10.7554/eLife.08413.017
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Figure 5. Gene expression analysis reveals that MP cells have an intermediate mesodermal (IM) identity. RNA
sequencing (RNA-seq) was used to analyze gene expression of MP cells. As a comparison, gene expression profiles
were analyzed for hES (ES) cells and their differentiated progeny, ME, EN and EC. (A) MP cells resemble
mesodermally differentiated cells. Hierarchical clustering analysis was performed for all genes with detectable
expression (reads per kilobase per million mapped reads [RPKM] values greater than 10) in one of the five cell
populations. Supplementary file 1 provides the complete list of genes shared between MP and ME (A) and genes
unique to MP (B). The complete RNA-seq data set for MP cells is provided in Supplementary file 2. (B) Correlation
of gene expression profiles. Genes with expression values (RPKM) expression between 10 and 1500 were plotted for
MP cells and ME. The correlation coefficient (R) for all expressed genes is 0.9522. (C) Schematic depicting
differentiation protocols from hES cells to IM and lateral plate mesoderm (LM) derivatives cardiomyocytes (CMs) and
hematopoietic stem and progenitor (HSP) cells. (D) QPCR analysis of IM, CM, HSP, and MP cells revealed that
MP cells have a similar expression profile as IM cells. ACT = Activin A, BMP = BMP4, CHR = CHIR98014, d = day,
FGF = FGF2, IWP = IWP-2, RA = retinoic acid, VGF = VEGF.
DOI: 10.7554/eLife.08413.018
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with a correlation coefficient of 0.9522 (Figure 5B). Although this analysis revealed that MP cells are
more similar to transient ME populations than they are to other cell populations examined, they are also
distinct from ME cells. In contrast to ME cells, MP cells exhibit significantly lower levels of pluripotency
regulators, including POU5F1 (OCT4) and SOX2. Several established early mesodermal markers (T,
MIXL) were significantly elevated in ME cells relative to MP cells, suggesting that MP cells have
progressed beyond this transient and early ME phenotype.
During development as the ME germ layer matures, modulation of various signaling molecule
pathways lead to its further specification into paraxial, intermediate, and lateral plate mesoderm (PM,
IM, and LM, respectively) (reviewed in Christ and Ordahl, 1995). IM develops into cells of the
urogenital system, whereas LM develops into tissues of the vascular system, including cardiomyocytes
(CMs) and hematopoietic stem and progenitor (HSP) cells. Using established differentiation protocols
(Figure 5C), we examined expression by qPCR of several mesodermal markers in MP cells relative to
IM, CM and HSP. Interestingly, MP cells most closely resembled the mesodermal gene expression
profile of IM cells (Figure 5D). In addition, we observed in the RNA-seq data that several IM markers
(CITED2, EYA1, GATA3, LHX1, SALL1) were expressed in MP cells (Supplementary file 2). Based on
this gene expression analysis we speculated that MP cells are most closely related to cells of
intermediate mesoderm and consequently renamed them from MP cells to intermediate mesodermal
progenitor cells (IMP).
IMP cells are restricted to differentiate towards an intermediate
mesoderm phenotype
Based on the above findings, we hypothesized that the differentiation potential of IMP cells may be
limited to cell types derived from IM, such as of the renal lineage. To test this hypothesis, we tested
the ability of IMP cells to differentiate into various mesodermally derived tissues, including
hematopoietic cells, CMs and renal progenitors. Using an established protocol for hematopoietic
differentiation (Figure 6A, adapted from Ng et al. (2008)), we successfully differentiated hES cells
into cells expressing SOX17, a marker of hemogenic endothelium, and CD34 and CD45, two cell
surface markers commonly used to monitor the presence of hematopoietic cell populations
(Figure 6B,C). In contrast, IMP cells derived from three independent hPSC lines and manipulated in
a similar manner failed to express these markers at detectable levels (Figure 6B,C), even when culture
periods were extended beyond the standard protocol.
Along similar lines, using an established protocol to derive CMs (Figure 6D, adapted from Lian
et al. (2012)), hES cells readily produced cardiac progenitors (CPs) and subsequently CMs, as
monitored by expression of NKX2.5 and ISL1 (Figure 6E). Cultures containing CMs exhibited the
characteristic contractile activity associated with such cells. In contrast, IMP cells subjected to these
same manipulations failed to express detectable levels of NKX2.5 and ISL1 (Figure 6E), and never
produced contractile activity. Furthermore, since CM differentiation from hES cells is enhanced by
inhibition of Wnt signaling (Willems et al., 2011), we reasoned that a prolonged withdrawal of CHR (a
potent Wnt agonist required to maintain IMP cells) and addition of IWP (a potent Wnt inhibitor) may
encourage IMP cells to enter the CM lineage. However, under no tested conditions were we able to
promote CM differentiation from IMP cells. Taken together, IMP cells were unable to differentiate into
cells with hematopoietic or cardiogenic properties, both derivatives of LM.
Since the IMP cells described in this study failed to generate derivatives of LM, we reasoned that
these cells may differentiate into cell populations derived from IM, such as kidney and gonads. To test
this possibility, we employed a published protocol to differentiate hES cells into renal progenitors
(Figure 7A) (Taguchi et al., 2014). This protocol employed several GFs and SMs to promote the
differentiation of hES cells to IM and subsequently metanephric mesenchyme (MM). Importantly, IMP
cells efficiently acquired gene expression signatures associated with IM and MM as monitored by
qPCR (Figure 7B). The gene expression profile of IMP-derived MM exhibited a striking similarity to
that of fetal kidney cells. PAX2 and SIX2 were upregulated at day 14 of renal differentiation, indicating
commitment to the kidney lineage (Bush et al., 2013). Furthermore, immuno-fluorescence analysis
demonstrated that a significant number of cells expressed IM and MM markers PAX2, SALL1, SIX2,
WT1 and CDH1 (E-cadherin) (Figure 7C–E). These results suggested that IMP cells, as predicted by
the gene expression profile, are restricted to IM and effectively differentiate into cells expressing
genes associated with a renal phenotype.
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To further assess the ability of the IMP cells to generate cells with renal properties, we employed
two rat explant assays that represent stringent measures of renal potential. In the first assay,
we co-cultured IMP-derived MM cells with dissected embryonic rat spinal cords (SCs), a tissue that
produces potent nephrogenic inductive signals (Figure 8A) (Kispert et al., 1998; Osafune et al.,
2006; Gallegos et al., 2012). In this system, IMP-derived MM cells readily acquired expression of
markers associated with renal cell types, including Lotus tetragonolobus lectin (LTL), CDH1, SALL1
and SIX2 (Figure 8B). In contrast, undifferentiated hES cells failed to express of SIX2 (Figure 8C),
indicating that MM properties are required for efficient renal differentiation. Although IMP-derived
Figure 6. IMP cells are unable to differentiate to cell types derived from lateral plate mesoderm (LM). (A) Schematic
of the hematopoietic differentiation protocol. Cells were differentiated in a step-wise manner using the indicated
GFs and SMs from undifferentiated ES cells or from IMP cells to ME, endothelial cell (ENC) and subsequently to
hematopoietic precursors (HPs). Stage-specific marker genes and cell surface markers expressed during this
differentiation process are indicated at the top. FGF = FGF2, VGF = VEGF, SCF = Stem Cell Factor, BMP = BMP4.
(B) QPCR analysis of hES and MP cells differentiated towards HPs. Compared to hES cells, IMP cells do not
differentiate towards HPs, as indicated by the absence of SOX17 expression. (C) Flow cytometry analysis of hES and
IMP cells differentiated towards HPs for CD34 and CD45. While hESC cells can differentiate into CD34+ CD35+ HPs,
IMP cells fail to differentiate generate cells positive for CD34 and CD45. (D) Schematic of the CM differentiation
protocol. Cells were differentiated in a step-wise manner using the indicated GFs and SMs from undifferentiated ES
cells or from IMP cells to ME, cardiac progenitor (CP) and subsequently to CM. Stage-specific marker genes
expressed during this differentiation process are indicated at the top. CHR = CHIR98014, IWP = IWP-2. (E) QPCR
analysis of MP cells differentiated towards CMs. Compared to hES cells, IMP cells do not differentiate towards CMs,
as indicated by the absence of ISL1 and NKX2.5 expression.
DOI: 10.7554/eLife.08413.019
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MM cells expressed several markers associated with the renal lineage, they failed to generate tubule-
like structures, including the nephron, suggesting that IMP cells differentiate effectively into a
sub-population of kidney cells. These co-culture experiments demonstrate that IMP cells efficiently
generate cell types with renal characteristics.
In a second assay, rat embryonic kidneys were dissociated to single cells and re-aggregated to
form kidney-like organoids (Unbekandt and Davies, 2010; Davies and Chang, 2014). These
aggregation experiments were performed in the presence of either IMP-derived MM cells (Figure 9A)
or undifferentiated hES cells (control), thereby assessing the renal potential of these cells. The
contribution of human cells to the re-aggregated rat kidneys is readily detected by staining for the
Figure 7. Differentiation of IMP cells into metanephric mesenchyme (MM). (A) Schematic of the differentiation
protocol. Cells were differentiated in a step-wise manner using the indicated GFs and SMs from undifferentiated ES
cells or from IMP cells to IM and subsequently to MM. Stage-specific marker genes expressed during this
differentiation process are indicated at the top. ACT = ActivinA, BMP = BMP4, CHR = CHIR98014, d = day,
FGF = FGF2, RA = retinoic acid. (B) Upon differentiation towards MM, cells expressed genes associated with kidney
lineage. QPCR was performed on ES and IMP cells for the indicated genes at various time points. Fetal kidney RNA
(11 gestation weeks) was used as a control. The data is displayed as a heat map with black corresponding to minimal
expression and red corresponding to maximal levels. (C–E) IF analysis of MP cell-derived MM. IMP cells were
differentiated as depicted in panel A, fixed and stained for the indicated proteins and DNA (DAPI). Numbers refer to
percentages of cells expressing the protein of interest. Standard deviation represents the variation between the
fields of view used for counting (n = 20). Scale bar = 100 μm.
DOI: 10.7554/eLife.08413.020
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human specific nuclear antigen (HuNu). In this assay, we consistently observed efficient incorporation
of IMP-derived MM cells into the kidney organoids (Figure 9B, Figure 9—figure supplement 1).
Interestingly, we primarily observed incorporation of these cells into the mesenchyme surrounding
epithelial structures, which were visualized by staining with lectin Dolichos biflorus agglutinin (DBA).
Furthermore, incorporated human cells expressed FOXD1, the expression of which is restricted to
metanephric stromal mesenchyme (Hatini et al., 1996) and stained with LTL (Figure 9C, Figure 9—figure
supplement 2). In contrast, undifferentiated hES cells failed to incorporate into these kidney organoids
(Figure 9D, Figure 9—figure supplement 3) and instead were found adjacent to the organoid structures
(Figure 9—figure supplement 3, bottom row). Taken together, these co-culture experiments establish
that IMP cells efficiently incorporated into the developing kidney.
Discussion
In this study, we describe a novel progenitor cell population derived from hPSCs with the potential to
differentiate into tissues of the IM lineage. By using the ACME screening technology, we were able to
simultaneously define and optimize derivation and expansion conditions for these intermediate
mesodermal progenitor (IMP) cells. Although it was our initial intention to produce a progenitor cell
population with broad differentiation potential into all mesodermally-derived tissues, we made the
surprising finding that the differentiation potential of these IMP cells was restricted to the IM lineage.
Consequently, we were unable to coax IMP cells to differentiate into cell types derived from LM, such as
blood and CMs. This exquisite lineage restriction was particularly surprising in light of the expression of
multiple pan-mesodermal marker genes, such as LHX1, MESP1 and MIXL1. Given their ability to
differentiate into cell types with gene expression patterns associated with renal lineages, we hypothesize
that this IMP cell population is an in vitro counterpart to intermediate mesoderm. It will be interesting to
investigate whether IMP cells are capable of differentiating into other derivatives of intermediate
mesoderm, such as the Wolffian and Mu¨llerian ducts of the developing reproductive system.
Figure 8. Assessment of renal potential of IMP cells. (A) Schematic of spinal cord (SC) co-culture assay to assess
renal differentiation potential of IMP cells. IMP cells were differentiated as depicted in Figure 7A and incubated in
liquid–air interface cultures with rat embryonic SC explants. (B) Immuno-fluorescence analysis of markers expressed
in renal progenitors. 4 days after co-cultures were established, cells were fixed and stained for the indicated proteins
(ECAD, SIX2 and SALL1) and for Lotus-tetragonolobus lectin (LTL). The dashed line indicates the boundary between
human cells and the SC explant. Scale bar = 100 μm. (C) Undifferentiated hES cells failed to express SIX2 when
co-cultured with embryonic rat SCs. Scale bar = 100 μm.
DOI: 10.7554/eLife.08413.021
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Figure 9. Incorporation of IMP cells into kidney mesenchyme. (A) Schematic of a re-aggregation assay to test renal
potential. IMP cells were differentiated as depicted in Figure 7A and mixed with dissociated embryonic rat kidneys
at a ratio of 7.5:92.5 and co-incubated for 4 days to form organoids in media-air interface co-culture.
(B) Representative images of re-aggregated kidney organoids. IMP cells differentiated to MM are detected with the
human specific nuclear antigen HuNu (green). Human cells are clearly integrated into renal organoids and surround
epithelial structures labeled with the lectin Dolichos biflorus agglutinin (DBA) (red). Figure 9—figure supplement 1
provides additional images of MP cells incorporating into renal structures. Scale bar = 25 μm. (C) Representative
images of re-aggregated kidney organoids. Renal organoids were labeled with DAPI (blue) to identify nuclei, HuNu
(green) to identify human cells and with either FOXD1 antibody or LTL (red). Two representative sets of images are
shown to indicate co-localization of FOXD1 in HuNu positive cells. Scale bar = 25 μm. (D) Undifferentiated hES cells
failed to integrate into renal organoids. Instead of MP cells, undifferentiated ES cells were mixed with dissociated
embryonic rat kidneys. These cells failed to integrate into the renal organoid structures as indicated by the lack of
HuNu staining. Figure 9—figure supplement 2 demonstrates that undifferentiated ES cells fail to incorporate into
these structures. Scale bar = 25 μm.
DOI: 10.7554/eLife.08413.022
The following figure supplements are available for figure 9:
Figure supplement 1. Additional assessment of renal potential of MP cells.
DOI: 10.7554/eLife.08413.023
Figure 9. continued on next page
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Generation of expandable, lineage restricted progenitor cell populations offers several advantages
over the use of undifferentiated hPSCs in tissue engineering approaches. First, differentiated cultures
derived directly from hPSCs often harbor undifferentiated cells, which retain the potential to seed
tumor growth. Such tumor-initiating potential is problematic when cells are intended for trans-
plantation to repair or replace damaged tissue. Based on our sub-cutaneous injections into immune-
compromised mice, IMP cells do not grow into teratomas, a defining property of undifferentiated
pluripotent stem cells. Our gene expression analysis provides further evidence of this loss of
pluripotency and hence of teratoma-seeding potential: IMP cells express nearly undetectable levels of
pluripotency markers, such as POU5F1/OCT4 and SOX2, both of which show residual expression in
mesodermally differentiated hPSCs. Second, lineage-restricted progenitors require less elaborate
manipulation to derive more mature cell populations. In the case of the IMP cells, early differentiation
steps to usher cells into a mesodermal lineage are no longer needed, thereby truncating
differentiation protocols to derive more mature cell populations. A third benefit for using expanded
progenitor cells is that such cultures are often quite homogenous. In contrast, hPSC cultures
instructed to differentiate into a specific lineage generally contain other cell types. Therefore, the
yield of more mature cell types upon subsequent differentiation is higher when starting with a
homogenous, lineage restricted cell population than when starting with undifferentiated hPSCs.
The conditions that we developed for the culture and expansion of IMP cells are fully defined and
free from animal-derived components, which will be important when cells are intended for therapeutic
applications. Moreover, these optimized conditions are robust, as demonstrated by their ability to
support derivation and expansion of IMP cells from two hES (H9 and Hues9) and one hiPS (RiPS) cell
lines. Additionally, IMP cells grown in these optimized conditions can be frozen and thawed without
any detectable effect on proliferative capacity or differentiation potential. Finally, these optimized
conditions allow for near unlimited expansion to quantities (∼1020) necessary for drug screening or
regenerative medicine purposes (Chen et al., 2013).
Expandable lineage restricted cell populations have been developed for other lineages, including
the neural and EN lineages. Several protocols have been described for the derivation of neural
progenitor (NP) cells, which can proliferate extensively and differentiate into all the neural lineages
and supporting cells (neurons, astrocytes, and oligodendrocytes) that compromise the central nervous
system (Reubinoff et al., 2001; Shin et al., 2006; Chambers et al., 2009). EN progenitor (EP) cells
represent another example of lineage restricted progenitor cells (Cheng et al., 2012). These cells
retain the ability to differentiate into endodermally derived tissues, including liver and pancreas.
Interestingly, differentiation into functional beta-cells is greatly improved when starting with EP cells
compared to undifferentiated hPSCs.
Although both EP and IMP cells exhibit restriction with respect to their developmental potency,
IMP cells are more severely restricted as they fail to produce certain mesodermally-derived cell
populations, such as blood and heart muscle. We currently do not understand the mechanism by
which the culture conditions defined for the derivation and expansion of IMP cells lead to this highly
restricted developmental potential. During embryogenesis, as the mesoderm emerges and migrates
from the primitive streak, it is further specified into PM, LM, and IM. Interestingly, both FGF and WNT/
β-catenin signaling regulate this ME cell specification, migration, and proliferation (Ciruna and
Rossant, 2001; Sweetman et al., 2008; Aulehla and Pourquie, 2010).
Along similar lines, modulation of the certain signaling pathways, such as WNT, can further refine
and specify the differentiation potential of hPSC-derived progenitors. For example, we previously
showed that levels of WNT/β-catenin signaling instruct the positional identity of NPCs and, upon
subsequent differentiation, of the resulting neuronal cell population (Moya et al., 2014). Specifically,
high levels of WNT signaling instructed NP cells to adopt a posterior fate, consistent with WNT’s role
in posterior patterning during development. In a separate study, the level of WNT activation achieved
through GSK3-β inhibition was found to directly influence the ME subtype of differentiating hPSCs
Figure 9. Continued
Figure supplement 2. Staining controls relevant to Figure 9C.
DOI: 10.7554/eLife.08413.024
Figure supplement 3. Additional assessment of renal potential of MP cells.
DOI: 10.7554/eLife.08413.025
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(Mendjan et al., 2014). We speculate that continuous activation of the WNT and FGF signaling
pathways is acting not only to stabilize the IMP cell state, but also to restrict its differentiation
potential to cell types derived from the IM lineage.
The development of lineage-restricted progenitors offers an opportunity to investigate
mechanisms by which specific developmental stages can be paused. Recent studies to profile
epigenetic changes during the differentiation of hPSCs to pancreatic beta cells indicate that specific
chromosomal regions open during specific windows of differentiation, thereby conferring a certain
developmental competence to sequentially acquire increased lineage restriction (Wang et al., 2015).
In the future, the intermediate mesodermally restricted cell population described here can provide a
further window into the mechanisms by which developmental competence is established and
maintained.
Materials and methods
hPSC culture
Human ES cell lines H9 and Hues9 were obtained from WiCell and Harvard University, respectively. All
experiments described in this study were approved by a Stem Cell Research Oversight Committee
(Protocol #100210ZX, PI Willert). The human induced pluripotent stem cell line BJ RiPS (Warren et al.,
2010) was provided under a Material Transfer Agreement from Dr D Rossi (Childrens Hospital Boston,
MA, United States). The H9 line carrying GFP in the SOX17 locus (Wang et al., 2011) was provided
under a Material Transfer Agreement from Dr Seung Kim (Stanford School of Medicine). The following
media were used: BJ RiPS and Hues 9 ES (DMEM/F12 mixed, 20% (vol/vol) Knockout Serum
Replacement, 1% (vol/vol) penicillin-streptomycin, 1% (vol/vol) nonessential amino acids, 2 mM
L-glutamate, 0.1 mM β-mercaptoethanol and 10 ng/ml FGF2 (PeproTech)); H9 ES (DMEM/F12
supplemented with L-Ascorbic Acid, Selenium, Transferrin, NaHCO3, Insulin, TGFβ1, and FGF2 as
described previously (Chen et al., 2011)). Fresh media was added daily to all cells. Every 5 days,
colonies were enzymatically passaged with Accutase (Thermo Fisher Scientific, Waltham, MA, United
States) and transferred to a Matrigel-coated culture dish. All media components are from Thermo
Fisher Scientific unless indicated otherwise. For all experiments, hPSCs were used between passages
20 and 50 in this study.
Array fabrication and characterization
ACME slides were fabricated as previously described (Brafman et al., 2012). Briefly, glass slides were
cleaned, silanized, and then functionalized with a polyacrylamide gel layer. For ECMP arrays, stock
solutions of ECMPs were suspended at 250 μg/ml in ECMP printing buffer (100 mM acetate, 5 mM
EDTA, 20% [vol/vol] glycerol and 0.25% [vol/vol] Triton X-100, pH 5.0). ECMP solutions were mixed in
all possible 128 combinations in a 384-well plate. For GF and SM arrays, stock solutions were
suspended at 1 mg/ml in soluble factor printing buffer (100 mM acetate, 5 mM EDTA, 19% glycerol
[vol/vol] and 0.25% [vol/vol] Triton X-100, 10 mM trehalose dehydrate [Sigma], 1% poly(ethylene
glycol), pH 5). GF solutions were then mixed into 400 combinations representing all single, pairwise,
and non-redundant three-way combinations possible in a 384-well plate. The following ECMPs, GFs,
and SMs (Product/Vendor/Catalog #/Concentration) were used: Collagen I/Sigma–Aldrich (St. Louis,
MO, United States)/C7774/250 μg/ml, Collagen III/Sigma–Aldrich/C4407/250 μg/ml, Collagen IV/
Sigma–Aldrich/C7521/250 μg/ml, Collagen V/Sigma–Aldrich/C3657/250 μg/ml, Fibronectin/Sigma–
Aldrich/F2518/250 μg/ml, Laminin/Sigma–Aldrich/L6274/250 μg/ml, Vitronectin/Sigma–Aldrich/
V8379/250 μg/ml, Wnt3a/In House/100 ng/ml, R-Spondin/In House/100 ng/ml, CHIR98014/Selleck
Chemicals (Houston, TX, United States)/S2745/50 ng/ml, Dkk-1/R&D Systems (Minneapolis, MN,
United States)/5439-DK-010/50 ng/ml, IWP-2/Tocris (United Kingdom)/3533/50 ng/ml, FGF/Thermo
Fisher Scientific/13256-029/40 ng/ml, KGF/Thermo Fisher Scientific/PHG0094/50 ng/ml, VEGF/R&D
Systems/293-VE-010/50 ng/ml, EGF/R&D Systems/236-EG-01M/50 ng/ml, SHH/R&D Systems/464-
SH-025/50 ng/ml, Cyclopamine/Tocris/1523/50 ng/ml, BMP4/R&D Systems/314-BP-010/50 ng/ml,
Activin/R&D Systems/338-AC-010/50 ng/ml, Dorsomorphin/Sigma–Aldrich/P5499-5MG/50 ng/ml, SB
431542/Tocris/1614/50 ng/ml, Noggin/R&D Systems/6057-NG-025/50 ng/ml. The hit ECMP
condition from the primary screen was used as a substrate to print the GFs and SMs in the second
screen. 20 individual spots of each protein/GF/SM mixture, clustered into groups of five and printed in
different quadrants of the slide, were deposited with a 450 μm pitch on the acrylamide gel pad using a
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SpotBot Personal Microarray Printer (ArrayIt, Sunnyvale, CA, United States) equipped with Stealth
SMP 4.0 split pins. The pins were cleaned by sonication in 5% Micro Cleaning Solution (ArrayIt) and
dH2O immediately before use. Between each sample in the source plate, the pins were dipped in a
50% DMSO and water solution, washed for 25 s with dH2O and dried.
Slide imaging, quantification, and analysis
Slides were fixed with 4% PFA for 10 min at room temperature (RT) and washed with PBS. Slides were
imaged using the CellInsight CX5 High Content Screening (HCS) Platform (Thermo Fisher Scientific).
The system was programmed to visit each spot on the array, perform autofocus, and acquire DAPI and
FITC (GFP). Cell counts and stain intensities were measured using Thermo Fisher Scientific HCS Studio
2.0 Software using the built-in object identification and cell intensity algorithms.
MP/IMP cell derivation and culture
Undifferentiated hPSCs were re-plated on Matrigel at a density of 3 × 103 cells/cm2 and cultured in ES
cell culture medium for 4 days. To direct cells to the mesoderm lineage, the media was switched to
serum free differentiation media (consisting of RPMI 1640, 1× B27 minus Insulin, and 1% [vol/vol]
penicillin-streptomycin). Cells were treated with 10 μMCHIR-98014 (CHR, Tocris) for the first 24 hr and
then allowed to recover for an additional 24 hr without CHR. Tissue culture plates were incubated with
ECMP coating buffer (PBS with 15 ng/ml Collagen I [C1], 15 ng/ml Collagen III [C3], 15 ng/ml Collagen
IV [C4], 50 ng/ml FN, 15 ng/ml VN) overnight at 37˚ with volume sufficient to coat the surface area of
the well. Mesoderm (48 hr) cells were single-cell passaged with Accutase and replated onto C1 C3 C4
FN VN-coated plates at a density of 3.5 × 103 cells/cm2 in serum free differentiation media
supplemented with 1 μM CHR and 20 ng/ml FGF. Media was also supplemented with 10 μM Y27632
(Wako, Richmond, VA, United States) for improve passaging efficiency. Optimal CHR concentration
varied with cell line; Hues 9 MP cells propagated in colonies most efficiently at 0.25 μM while BJ RiPS
cells did so at 0.05 μM. Manual picking of colonies in passage 1 improved MP/IMP expansion.
Differentiated cells around colonies were scraped away before passaging. Half the media was
changed the day after passaging and then full media changes were made every other day thereafter.
For routine passaging, MP/IMP cell cultures reaching 85% confluency were dissociated using a 0.5 mM
EDTA (in Ca2+/Mg2+-free PBS, pH 8.0) at RT for 5 min. MP cells were removed from the plate via
gentle washing with the EDTA solution. Using this method, MP cells were routinely passaged every
5–8 days.
Differentiation of hES cells to EN, EC and ME
EN differentiation
Human ES cells were differentiated to EN as previously described (D’Amour et al., 2005). Initiated on
days 4–6 after passage (depending on culture density), sequential, daily media changes were made for
the entire differentiation protocol. After a brief wash in PBS (with Mg/Ca), cells were cultured in RPMI
(without FBS), Activin A (100 ng/ml) and Wnt3a (25 ng/ml) (generated in house as described (Willert,
2008)) for the first day. The next day the medium was changed to RPMI with 0.2% vol/vol FBS and
Activin A (100 ng/ml), and the cells were cultured for 2 additional days. Definitive EN was collected at
day 3 for analysis.
EC differentiation
Human ES cells were differentiated to EC by modifying an established neural rosette protocol (Wilson
and Stice, 2006). 2 days before passaging hES cells, medium was changed to N2 medium (DMEM/
F12 with 1× N2). 1 day before passaging, medium was changed to N2 medium supplemented with
1 μM of Dorsomorphin (DSM) (cat# 171261; Calbiochem/EMD Millipore, Billerica, MA, United States).
The day of passaging, EBs were initiated by detaching cells with Accutase and gentle cell scraping.
2e6 H9 cells were used to seed one well of a 6-well low binding plate and placed on a rotating
platform (95 rpm) in a 37˚C incubator. 2 days later, medium was changed to N2 medium with 1 μM
DSM and media changes were made as needed until 8 days after EB formation, at which point EBs
were replated onto Matrigel-coated plates using NBF media (DMEM/F12 with 0.5× N2, 0.5× B-27, 20
ng/ml of FGF and 1% P/S) to form rosettes. 4–6 days after plating onto Matrigel, cells were collected
for analysis.
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Mesoderm differentiation
Human ES cells were differentiation to mesoderm as previously described (Lian et al., 2013). Once hES cells
were 50–60% confluent, medium was changed to serum free differentiation medium (RPMI supplemented
with 1× [vol/vol] B27 [without insulin]) with 10 μM CHIR-98014. After 24 hr, the medium was changed to
serum free differentiation medium without CHIR-98014. Cells were collected at 48 hr for analysis.
Human ES and IMP cell differentiation
Hematopoietic differentiation
Human ES and IMP cells were differentiated to the hematopoietic lineage as previously described
(Ng et al., 2008). ES cells were differentiated towards hematopoietic precursors first by ME induction
with 25 ng/ml human BMP4 for 4 days. IMP cells were treated as d4 ME, bypassing BMP4 treatment.
After mesoderm induction, cells were treated with 20 ng/ml FGF and 50 ng/ml human VEGF (Humanzyme)
for 4 days and then with 50 ng/ml Flt-3L (R&D Systems) and 150 ng/ml IL-6 (R&D Systems) for 4 days.
CM differentiation
Human ES and IMP cells were differentiated to the cardiac lineage as previously described (Lian et al.,
2012). Human ES cells were induced to mesoderm with 10 μM CHIR 98014 for 24 hr, then incubated
for 48 hr in serum free differentiation media. IMP cells were treated as d3 cultures, bypassing this
initial treatment. Cells were then treated with IWP-2 for 4 days, incubated for an additional 2 days in
serum free differentiation media, then supplemented with insulin at day 9.
Kidney differentiation
Human ES and IMP cells were differentiation to the kidney lineage as previously described (Taguchi
et al., 2014). In serum free differentiation media (SFDM; DMEM/F12 supplemented with 2% (vol/vol)
B27 (without retinoic acid), 2 mM L-glutamine, 1% (vol/vol) ITS, 1% (vol/vol) nonessential amino acids,
90 μM β-mercaptoethanol and 1% (vol/vol) penicillin/streptomycin), hES and MP cells were
aggregated at 10,000 cells per well in U-bottom 96-well low-cell-binding plates to form EBs. EBs
were formed in the presence of 10 μM Y27632 (Wako) and 0.5 ng/ml human BMP4 (Stemgent,
Lexington, MA, United States). After 24 hr, the SFDM was supplemented with 1 ng/ml human Activin
A and 20 ng/ml human FGF2. After 48 hr, the SFDM was supplemented with 0.5 ng/ml BMP4 and 10
μM CHIR. IMP cells were treated as d3 cultures, bypassing this initial treatment. Subsequently, half of
the culture medium volume was refreshed with new SFDM every other day. On day 9, the medium was
changed to SFDM supplemented with 1 ng/ml human Activin A, 0.5 ng/ml BMP4, 3 μM CHIR, and 0.1
μM retinoic acid. On day 11, the medium was changed to SFDM containing 1 μM CHIR and 5 ng/ml
FGF9. All data shown are representative examples of at least three independent experiments.
Quantitative RT-PCR
RNA was isolated using RNeasy Plus Micro Kit (Qiagen, Germany) reverse-transcribed with random
primers and qScript cDNA Supermix (Quanta, Gaithersburg, MD, United States). Before reverse
transcription, 5 μg of RNA was digested by RNase-free DNase I (Ambion/Thermo Fisher Scientific) to
remove genomic DNA. qPCR was carried out using a Real-Time PCR System (Bio-Rad, Hercules, CA,
United States) and Taqman qPCR Mix with a 10-min gradient to 95˚C followed by 40 cycles at 95˚C for
15 s and 60˚C for 1 min. The following Taqman (Thermo Fisher Scientific) gene expression assay
primers (Gene/ABI Assay #) were used: 18s/Hs99999901_s1, OCT4/Hs04260367_gH, NANOG/
Hs04399610_g1, SOX2/Hs01053049_s1, FOXA2/Hs00232764_m1, SOX1/Hs01057642_s1, MESP1/
Hs01001283_g1, MIXL1/Hs00430824_g1, LHX1/Hs00232144_m1, PDGFRA/Hs00998018_m1, PAX1/
Hs01071293_g1, TBX6/Hs00365539_m1, TCF15/Hs00231821_m1, MEOX1/Hs00244943_m1, NKX2.5/
Hs00231763_m1, ISL1/Hs00158126_m1, LMO2/Hs00153473_m1, KDR/Hs00911700_m1, PAX2/
Hs01057416_m1, EYA1/Hs00166804_m1, SALL1/Hs01548765_m1, OSR1/Hs01586544_m1, LHX1/
Hs00232144_m1, WT1/Hs01103751_m1, CITED2/Hs01897804_s1, PECAM1/Hs00169777_m1, HOXC9/
Hs00396786_m1, ITGA8/Hs00233321_m1, PBX1/Hs00231228_m1, HOXA10/Hs00172012_m1, HOXA11/
Hs00194149_m1, GDNF/Hs01931883_s1, FOXD1/Hs00270117_s1, SIX2/Hs00232731_m1, CDX2/
Hs01078080_m1, FGF5/Hs03676587_s1. Gene expression was normalized to 18S rRNA levels. Delta Ct
values were calculated as Ctargett −C18st . All experiments were performed with three technical
replicates. Relative fold changes in gene expression were calculated using the 2−ΔΔCt method
(VanGuilder et al., 2008).
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Antibodies
The following antibodies were used (Antibody/Vendor/Catalog #/Concentration): Rabbit anti-
NANOG/Santa Cruz Biotechnology (Dallas, TX, United States)/SC-33759/1:50, Rabbit anti-OCT4/
Santa Cruz/SC-9081/1:50, Mouse anti-MIXL1/R&D Systems/MAB2610/1:200, Mouse anti-PAX2/
Creative Diagnostics (Shirley, NY, United States)/DMABT-H14539/1:200, Rabbit anti-SIX2/Abcam
(Cambridge, MA, United States)/ab68908/1:200, Rabbit anti-WT1/Santa Cruz Biotechnology/sc-192/1:200,
Rabbit anti-SALL1/Abcam/ab31526/1:200, Mouse anti-E Cadherin/Abcam/ab1416/1:200, Mouse anti-
Human Nuclear Antigen/Abcam/ab191181/1:250, Goat anti-FOXD1/Santa Cruz Biotechnology/sc-47585/
1:200, Rabbit anti-Ki67/Abcam/ab15580/1:250, APC anti-human CD56 (NCAM)/BioLegend (San Diego,
CA, United States)/318309/5 μl per test, PE anti-human CD326 (EpCAM)/BioLegend/324205/5 μl per test,
Alexa-647 Mouse IgG2a Isotype Control/BD/558053/20 μl per test, PE Mouse IgG1 Isotype Control/
BioLegend/400113/5 μl per test, PE Mouse IgG2a Isotype Control/BD Biosciences (San Jose, CA, United
States)/561552/5 μl per test, Alexa 647 Donkey Anti-Goat/Thermo Fisher Scientific/A-21447/1:200, Alexa
647 Donkey Anti-Rabbit/Thermo Fisher Scientific/A-31573/1:200, Alexa 647 Donkey Anti-Mouse/Thermo
Fisher Scientific/A-31571/1:200, Alexa 546 Donkey Anti-Rabbit/Thermo Fisher Scientific/A-10040/1:200,
Alexa 546 Donkey Anti-Mouse/Thermo Fisher Scientific/A-10036/1:200, Alexa 488 Streptavidin Conjugate/
Thermo Fisher Scientific/S-11223/1:200, Alexa 488 Donkey Anti-Rabbit/Thermo Fisher Scientific/A-21206/
1:200, Alexa 488 Donkey Anti-Mouse/Thermo Fisher Scientific/A-21202/1:200.
Flow cytometry
Cells were dissociated with Accutase (Thermo Fisher Scientific) at 37˚C for 4 min and triturated using
fine-tipped pipettes. For intracellular antibody staining, cells were fixed for 15 min with Cytofix (BD
Biosciences), washed twice with flow cytometry buffer (PBS, 1 mM EDTA, and 0.5% FBS), permeabilized
with Cytoperm (BD Biosiences) for 30 min on ice, and washed twice with flow cytometry buffer, and
resuspended at a maximum concentration of 5 × 106 cells per 100 μl. Cells were incubated with primary
antibodies on ice for 1 hr, washed twice with flow cytometry buffer. If necessary, cells were incubated
with secondary antibodies on ice for 1 hr and then washed three times. After passing through a 40 μm
cell strainer, cells were resuspended in flow cytometry buffer at a final density of 2 × 106 cells ml−1.
Propidium iodide (Sigma) was added at a final concentration of 50 mg ml−1 to exclude dead cells. Cells
were analyzed on the FACS Fortessa (Becton Dickinson). For each sample, at least three independent
experiments were performed. Results were analyzed using FlowJo software.
Immunocytochemistry
Monolayer cultures were gently washed with PBS prior to fixation. Cultures were fixed for 10 min at
4˚C with fresh paraformaldehyde (4% [wt/vol] in PBS). For sectioning aggregates of cells in suspension,
samples were fixed with 4% paraformaldehyde, embedded in optimal cutting temperature compound
(Tissue Tek) and cryo-sectioned at 10-μm thickness before staining, Cells were blocked and
permeabilized with 2% (wt/vol) BSA, 0.2% ([vol/vol] in PBS) Triton X for 30 min at RT. Cells were then
washed twice with PBS. Primary antibodies were incubated overnight at 4˚C and washed twice with
PBS. Secondary antibodies were incubated for 1 hr at 37˚C. Antibodies used are as listed above. Prior
to imaging, samples were stained with DAPI for 10 min, washed and mounted in Vectashield (Vector
Laboratories, Burlingame, CA, United States), covered with coverslips, and sealed with nail polish.
Images were taken using an Olympus FluoView1000 multi-photon confocal microscope. All IF analyses
were repeated a minimum of three times and representative images are shown.
High throughput RNA-seq
Total RNA was isolated from cells, depleted of genomic DNA and rRNA and fragmented to ∼200 bp
by RNase III. After ligating the Adaptor Mix, fragmented RNA was converted to the first strand cDNA
by ArrayScript Reverse Transcriptase (Ambion/Thermo Fisher Scientific), size selected (100–200 bp) by
gel electrophoresis, and amplified by PCR using adaptor-specific primers. Deep sequencing was
performed on an Illumina (San Diego, CA, United States) Genome Analyzer II. Analysis of genome-
wide expression data was performed as previously described (Trapnell et al., 2012, 2013). Briefly,
raw reads were aligned to the reference human genome (hg19) using TopHat. Cufflinks was used to
assemble individual transcripts from the mapped reads. Cuffmerge was used to merge the assembled
transcripts from the two biologically independent samples. Cuffdiff was used to calculate gene
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expression levels and test for the statistical significance of differences in gene expression. Reads per
kilobase per million mapped reads were calculated for each gene and used as an estimate of
expression levels. The full RNA-seq data set for the IMP cells is provided in Supplementary file 2.
SC co-culture assay
hES or IMP-derived MM cells were cultured with mouse embryonic SC taken from E11.5 or E12.5
embryos at the air-fluid interface on a polycarbonate filter (0.8 mm; Whatman/Sigma-Aldrich) fed with
DMEM containing 10% fetal calf serum, as described previously (Kispert et al., 1998; Osafune et al.,
2006; Gallegos et al., 2012; Martovetsky et al., 2013).
Re-aggregation assay
The re-aggregation assay was performed as previously described (Unbekandt and Davies, 2010;
Davies and Chang, 2014). To prepare the kidney tissue for recombination, embryonic kidneys from
12.5–13.5-dpc (days post coitum) mice were isolated and dissected free of surrounding tissues as
previously described (Gallegos et al., 2012; Martovetsky et al., 2013). Briefly, embryonic kidneys
were digested with trypsin at 37˚C for 10 min and dissociated by manually pipetting. After the cells
had been filtered through a 100 μm cell strainer, 4–10 × 105 embryonic kidney cells were
recombined with 4% (by number) of hESC- or IMP-derived cells and then centrifuged at 400×g for
2 min to form a pellet. The pellet was allowed to aggregate by culturing in DMEM supplemented
with 10% FBS overnight in a sterile PCR tube. The following day, the aggregate was transferred to
the top of a Transwell polycarbonate filter (0.4 μm pore size). The filter was placed with the well of a
12-well dish to which DMEM supplemented with 10% FBS was added to bottom of the well. The
aggregate was then cultured for 4 days at the air-fluid interface before fixation and analysis. The
following lectins were used to stain organoid cultures (Lectin/Vendor/Catalog #/Concentration):
Biotinylated DBA/Vector Laboratories/B-1035/1:200, LTL, Biotinylated-LTL/Vector Labs/B-1325/1:
200. An Alexa 647 Streptavidin Conjugate (Thermo Fisher Scientific; S-21374) was used at 1:200 for
detection of these lectins.
Teratoma/Transplantation assay
For the subcutaneous injection, H9 hES or MP cells were dissociated, mixed with 250 μl Matrigel, and
transplanted subcutaneously into the thigh and shoulder of nude mice. Each mouse received two
injections of cells, one near the front legs and one near the hind legs. Teratoma formation was monitored
over a period of 4–12 weeks. A total of 3 mice were injected with 0.5 × 106 hES cells per site. All six
injection sites yielded teratomas of 10 mm or greater. Another 6 mice were injected with MP cells: 2 mice
received 0.5 × 106 cells per injection, 2 mice received 0.75 × 106 cells per injection, and 2 mice received
1.0 × 106 cells per injection. Of the 12 injection sites, only one site maintained a small lump of 1 mm that
did not grow in size. No MP cell injection yielded a growth of the size observed for hES cells. All animal
work was approved by the institutional IACUC committee (Protocol Number S06321, PI Willert).
Chromosome counting
Karyotype analysis was performed by Cell Line Genetics, Inc., Madison, Wisconsin, United States. For
each submitted MP cell line (H9 at passage 10 and H9_SOX17-GFP at passage 15 [Wang et al., 2011],
kindly provided by Dr Seung Kim, Stanford School of Medicine, Palo Alto, CA, United States
chromosome numbers were determined for 20 cells using G-banded metaphase spreads.
Statistical analyses
All averaged data are expressed ±standard error of the mean of three independent biological replicates
unless otherwise stated. For comparisons of discrete data sets, unpaired Student’s t-tests were performed
to calculate p-values between experimental conditions and controls and a p-value <0.05 was considered
statistically significant. For each ACME experiment, the ratio (Ri) of the log2 of the T-GFP signal and the
DNA signal was calculated for each spot. From this a differentiation z-score was calculated for each spot
ZDIF = (Ri − μDIF)/σDIF, where Ri was the ratio for the spot, μDIF was the average of the ratios for all spots on
each array, and σDIF was the S.D. of the ratios for all spots on each array. Differentiation z-scores from
replicate spots (n = 5 per condition) were averaged for each ECMP condition on the array. The replicate
average z-scores were displayed in a heat map with rows corresponding to individual conditions and
columns representing independent array experiments (n = 5 for each replicate). For each array
experiment, all columns were mean-centered and normalized to one unit S.D. The rows were clustered
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using Pearson correlations as a metric of similarity. All clustering was performed using Gene Cluster. The
results were displayed using a color code with red and green representing an increase and decrease,
respectively, relative to the global mean. All heat maps were created using Tree View. Global main effects
principal component analysis was performed as previously described (Box et al., 2005).
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